All the platinum(IV) derivatives bearing CLB from the study displayed superior cytotoxicity, most prominently toward cisplatin-resistant cancer cell lines, which was also confirmed by Qin et al. in a separate study [52]. This evidence concerns the gene CLYBL and cancer.